FBPase inhibitors for diabetes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S146000, C548S190000, C548S196000, C514S365000, C514S370000

Reexamination Certificate

active

07868030

ABSTRACT:
Compounds of formulaas well as pharmaceutically acceptable salts and esters thereof, wherein R1to R3have the significance given in the application and which can be used in the form of pharmaceutical compositions.

REFERENCES:
patent: 6906063 (2005-06-01), Scarborough et al.
patent: 7358257 (2008-04-01), Scarborough et al.
patent: WO 01/47935 (2001-07-01), None
patent: WO 2004/009118 (2004-01-01), None
Hof et al (1984): STN International HCAPLUS database, (Columbus, Ohio), Accession No. 1984:567016.
Saijo et al (1989): STN International HCAPLUS database, (Columbus, Ohio), Accession No. 1989:534189.
Database Chemcats, XP002451585.
Database Chemcats, XP002451586.
Database Chemcats, XP002451587.
Database Chemcats, XP002451588.
Database Chemcats, XP002451589.
Database Chemcats, XP002451590.
Database Chemcats, XP002451591.
Database Chemcats, XP002451592.
Database Chemcats, XP002451593.
Database Chemcats, XP002451594.
Database Chemcats, XP002451595.
Database Chemcats, XP002451596.
Database Chemcats, XP002451597.
Database Chemcats, XP002451598.
Hof H., et al., Arzneimittel Forschung, Drug Research 37(I), No. 3 (1987), XP002128088.
Rusching H., et al., Arzneimittel Forschung, Drug Research, vol. 8, No. 7a, pp. 448-454 (1958), XP009088824.
Husain M. I., et al., Indian Drugs, vol. 24, No. 1, pp. 21-23 (1986).
Van Poelje, P. D. et al,Diabetes, (2006) 55(6), 1747-1754.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

FBPase inhibitors for diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with FBPase inhibitors for diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FBPase inhibitors for diabetes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2704931

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.